Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset

详细信息    查看全文

• 作者：Rasa Ruseckaite ; Kerri Beckmann ; Michael O’Callaghan ; David Roder…
• 关键词：Prostate cancer ; Clinical registry ; Patterns of care ; South Australian ; Victorian Prostate Cancer Health Outcomes Research Data
• 刊名：BMC Research Notes
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：9
• 期：1
• 全文大小：914 KB
• 参考文献：1.Evans SM, Bohensky M, Cameron PA, McNeil J. A survey of Australian clinical registries: can quality of care be measured? Intern Med J. 2011;41(1a):42–8. doi:10.​1111/​j.​1445-5994.​2009.​02068.​x .CrossRef PubMed
  2.Evans SM, Scott IA, Johnson NP, Cameron PA, McNeil JJ. Development of clinical-quality registries in Australia: the way forward. Med J Aust. 2011;194(7):360–3.PubMed
  3.McNeil JJ, Evans SM, Johnson NP, Cameron PA. Clinical-quality registries: their role in quality improvement. Med J Aust. 2010;192(5):244–5.PubMed
  4.Reid CM. The role of clinical registries in monitoring drug safety and efficacy. Heart Lung Circ. 2015. doi:10.​1016/​j.​hlc.​2015.​04.​184 .
  5.Erekson EA, Iglesia CB. Improving patient outcomes in gynecology: the role of large data registries and big data analytics. J Minim Invasive Gynecol. 2015. doi:10.​1016/​j.​jmig.​2015.​07.​003 .
  6.Rosselli D, Rueda JD, Diaz CE. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015;26(4):733–8. doi:10.​4103/​1319-2442.​160175 .CrossRef PubMed
  7.O’Reilly GM, Gabbe B, Braaf S, Cameron PA. An interview of trauma registry custodians to determine lessons learnt. Injury. 2015. doi:10.​1016/​j.​injury.​2015.​06.​032 .
  8.GRACE. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141(2):190–9.CrossRef
  9.Hillert J, Stawiarz L. The Swedish MS registry—clinical support tool and scientific resource. Acta Neurol Scand Suppl. 2015;132(199):11–9. doi:10.​1111/​ane.​12425 .CrossRef
  10.Papadouka V, Schaeffer P, Metroka A, Borthwick A, Tehranifar P, Leighton J et al. Integrating the New York citywide immunization registry and the childhood blood lead registry. J Public Health Manag Pract. 2004;Suppl:S72–80.
  11.Pates RD, Scully KW, Einbinder JS, Merkel RL, Stukenborg GJ, Spraggins TA, et al. Adding value to clinical data by linkage to a public death registry. Stud Health Technol Inform. 2001;84(Pt 2):1384–8.PubMed
  12.Pathy NB, Yip CH, Taib NA, Hartman M, Saxena N, Iau P, et al. Breast cancer in a multi-ethnic Asian setting: results from the Singapore–Malaysia hospital-based breast cancer registry. Breast. 2011;20(Suppl 2):S75–80. doi:10.​1016/​j.​breast.​2011.​01.​015 .CrossRef PubMed
  13.Stern M, Wiedemann B, Wenzlaff P. From registry to quality management: the German cystic fibrosis quality assessment project 1995 2006. Eur Respir J. 2008;31(1):29–35. doi:10.​1183/​09031936.​00056507 .CrossRef PubMed
  14.Evans S, Nag N, Roder D, Brooks A, Millar J, Moretti K, et al. Development of the International Prostate Cancer Outcomes Registry. BJU Int. 2015. doi:10.​1111/​bju.​13258 .
  15.Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014. doi:10.​1016/​S0140-6736(14)62038-9 .PubMed
  16.Gilhodes J, Belot A, Bouvier AM, Remontet L, Delafosse P, Ligier K, et al. Incidence of major smoking-related cancers: trends among adults aged 20–44 in France from, 1982 to 2012. Cancer Epidemiol. 2015. doi:10.​1016/​j.​canep.​2015.​07.​001 .PubMed
  17.Lautrup CK, Mikkelsen EM, Lash TL, Katballe N, Sunde L. Familial colorectal cancer risk may be lower than previously thought: a Danish cohort study. Cancer Epidemiol. 2015. doi:10.​1016/​j.​canep.​2015.​07.​004 .PubMed
  18.Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788–97. doi:10.​1111/​ddg.​12690 .PubMed
  19.Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990–2010. JAMA Oncol. 2015;1(1):88–96. doi:10.​1001/​jamaoncol.​2014.​161 .CrossRef PubMed
  20.Beckmann K, Pinnock C, Tamblyn D, Kopsaftis T, AMF S, Roder D. Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort. Clin Oncol. 2009;5:247–56.
  21.Evans S, Millar J, Davis C, Murphy D, Bolton D, Giles G, et al. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. MJA. 2013;198(10):540–5.PubMed
  22.Smith D, King M, Egger S, Berry M, Stricker P, Cozzi P, et al. Quality of life 3 years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:B4817.PubMedCentral CrossRef PubMed
  23.Gandaglia G, Bray F, Cooperberg MR, Karnes RJ, Leveridge MJ, Moretti K, et al. Prostate cancer registries: current status and future directions. Eur Urol. 2015. doi:10.​1016/​j.​eururo.​2015.​05.​046 .
  24.Lee DH, Lee SH, Rha KH, Choi IY, Lee JY, Kim SW, et al. The establishment of K-CaP (the Multicenter Korean Prostate Cancer Database). Korean J Urol. 2013;54(4):229–33. doi:10.​4111/​kju.​2013.​54.​4.​229 .PubMedCentral CrossRef PubMed
  25.Lycken M, Garmo H, Adolfsson J, Stattin P, Holmberg L, Bill-Axelson A. Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based study. Eur J Cancer. 2014;50(10):1789–98. doi:10.​1016/​j.​ejca.​2014.​03.​279 .CrossRef PubMed
  26.Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010;28(6):1069–74. doi:10.​1200/​jco.​2009.​26.​2469 .PubMedCentral CrossRef PubMed
  27.AIHW. Cancer in Australia: an overview 2010. Canberra: AIHW; 2010.
  28.Evans S, Millar J, Wood J, Davis I, Bolton D, Giles G, et al. The prostate cancer registry: monitoring paterns and quality of care for men diagnosed with prostate cancer. BJUI. 2012;111:e158–66.CrossRef
  29.Evans S, Millar J, Frydenberg M, Murphy D, Davis C, Spelman T, et al. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry. BJUI. 2013. doi:10.​1111/​bju.​12509 .
  30.Adami H, Bergstrom R, Mohner M, Zatosnki W, Storm H, Ekbom A, et al. Testicular cancer in nine Northern European countries. Int J Cancer. 1994;59:33–8.CrossRef PubMed
  31.Coleman M, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancert. 2011;377:127–38.CrossRef
  32.Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: a 2000–2002 period analysis of EUROCARE-4 data. Lancert. 2007;8:784–96.
  33.Australian Bureau of Statistics. http://​www.​abs.​gov.​au . 2015.
  34.VIC-PCR. Victorian Prostate Cancer Clinical Registry (PCR). In: http://​www.​pcr.​registry.​org.​au/​Home.​aspx . 2008. 2015.
  35.Victorian Cancer Registry. http://​www.​cancervic.​org.​au/​research/​registry-statistics/​vcr . 2015.
  36.SA-PCCOC. South Australian prostate cancer clinical outcome collaborative 1998. 2015.
  37.Hutchings A, Neuburger J, Frie K, Black N, Van der Meulen J. Factors associated with non-response in routine use of patient reported outcome measures after elective surgery in England. Health Qual Life Outcomes. 2012;10(34):1–8.
  38.Australian Institute of Health and Welfare. A snapshot of men’s health in regional and remote Australia. Canberra: AIHW2010 Contract No: at. no. PHE 120.
  39.Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. A contemporary prostate cancer grading system: a validated alternative to the gleason score. Eur Urol. 2015. doi:10.​1016/​j.​eururo.​2015.​06.​046 .
  40.AJCC. Prostate Cancer Staging. https://​www.​cancerstaging.​org/​references-tools/​quickreferences/​Documents/​ProstateSmall.​pdf . American Joint Committee on Cancer. 2015.
  41.Hodgkinson K, Butow P, Hobbs KM, Hunt GE, Lo SK, Wain G. Assessing unmet supportive care needs in partners of cancer survivors: the development and evaluation of the cancer survivors’ partners unmet needs measure (CaSPUN). Psycho-Oncology. 2007;16(9):805–13.CrossRef PubMed
  42.Jocham H, Dassen T, Widdershoven G, Halfensm R. Quality of life in palliative care cancer patients: a literature review. Cancer Palliat Care. 2006. doi:10.​1111/​j.​1365-2702.​2006.​01274.​x .
  43.Choi IY, Park S, Park B, Chung BH, Kim CS, Lee HM, et al. Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system. Prostate Int. 2013;1(2):59–64. doi:10.​12954/​pi.​12015 .PubMedCentral CrossRef PubMed
  44.Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004;171(4):1393–401. doi:10.​1097/​01.​ju.​0000107247.​81471.​06 .CrossRef PubMed
  45.Noone AM, Schussler N, Negoita S, Adamo M, Cronin K, Cyr J, et al. Availability of TNM staging data elements in the medical record and training needs assessment: results from the 2014 SEER training needs assessment for TNM study. J Registry Manag. 2015;42(2):40–6.PubMed
  46.Szymanski K, Wei J, Dunn R, Sanda M. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76(5):1245–50.PubMedCentral CrossRef PubMed
  
• 作者单位：Rasa Ruseckaite (1)
  Kerri Beckmann (2)
  Michael O’Callaghan (3) (4) (5)
  David Roder (2)
  Kim Moretti (2)
  John Zalcberg (1)
  Jeremy Millar (6)
  Sue Evans (1)
  
  1. Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
  2. Centre for Population Health, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia
  3. South Australian Prostate Cancer Clinical Outcomes Collaborative, Department of Urology, Repatriation General Hospital, Adelaide, SA, Australia
  4. Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, SA, Australia
  5. Freemasons Foundation Centre for Men’s Health and Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia
  6. William Buckland Radiation Oncology Department, the Alfred, Melbourne, VIC, Australia
  
• 刊物主题：Biomedicine general; Medicine/Public Health, general; Life Sciences, general;
• 出版者：BioMed Central
• ISSN：1756-0500

文摘

Background Prostate cancer is the most commonly diagnosed and prevalent malignancy reported to Australian cancer registries, with numerous studies from single institutions summarizing patient outcomes at individual hospitals or States. In order to provide an overview of patterns of care of men with prostate cancer across multiple institutions in Australia, a specialized dataset was developed. This dataset, containing amalgamated data from South Australian and Victorian prostate cancer registries, is called the South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset (SA-VIC PCHORD).